메뉴 건너뛰기




Volumn 16, Issue 7, 2014, Pages 414-420

OpT2mise: A randomized controlled trial to compare insulin pump therapy with multiple daily injections in the treatment of type 2 diabetes - Research design and methods

(41)  Aronson, Ronnie a   Cohen, Ohad b   Conget, Ignacio c   Runzis, Sarah d   Castaneda, Javier e   De Portu, Simona d   Lee, Scott f   Reznik, Yves g   Petrovski, G h   Kocsis, G i   Lalic, N j   Tildesley, H k   Priestman, B A l   Metzger, M m   Joyce, Carol n   Podgorski, G o   Conway, R p   Perkins, B q   Kooy, A r   Liebl, A s   more..


Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

EID: 84903543526     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2013.0363     Document Type: Article
Times cited : (18)

References (24)
  • 1
    • 57349160286 scopus 로고    scopus 로고
    • European association for the study of diabetes: Medical management of hyperglycaemia in type 2 diabetes mellitus: A consensus algorithm for the initiation and adjustment of therapy: A consensus statement from the american diabetes association and the european association for the study of diabetes
    • American Diabetes Association
    • Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B; American Diabetes Association; European Association for the Study of Diabetes: Medical management of hyperglycaemia in type 2 diabetes mellitus: A consensus algorithm for the initiation and adjustment of therapy: A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 2009;52:17-30.
    • (2009) Diabetologia , vol.52 , pp. 17-30
    • Nathan, D.M.1    Buse, J.B.2    Davidson, M.B.3    Ferrannini, E.4    Holman, R.R.5    Sherwin, R.6    Zinman, B.7
  • 2
    • 0242269000 scopus 로고    scopus 로고
    • The Treat-to-Target Trial: Randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients
    • DOI 10.2337/diacare.26.11.3080
    • Riddle MC, Rosenstock J, Gerich J, Insulin Glargine 4002 Study Investigators: The Treat-to-Target Trial: Randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. Diabetes Care 2003;26:3080-3086. (Pubitemid 37339502)
    • (2003) Diabetes Care , vol.26 , Issue.11 , pp. 3080-3086
    • Riddle, M.C.1    Rosenstock, J.2    Gerich, J.3
  • 3
    • 84859033619 scopus 로고    scopus 로고
    • Contributions of basal and postprandial hyperglycemia over a wide range of A1C levels before and after treatment intensification in type 2 diabetes
    • Riddle M, Umpierrez G, DiGenio A, Zhou R, Rosenstock J: Contributions of basal and postprandial hyperglycemia over a wide range of A1C levels before and after treatment intensification in type 2 diabetes. Diabetes Care 2011;34: 2508-2514.
    • (2011) Diabetes Care , vol.34 , pp. 2508-2514
    • Riddle, M.1    Umpierrez, G.2    Digenio, A.3    Zhou, R.4    Rosenstock, J.5
  • 4
    • 84864697623 scopus 로고    scopus 로고
    • The role of comfort and discomfort in insulin therapy
    • Aronson R: The role of comfort and discomfort in insulin therapy. Diabetes Technol Ther 2012;14:741-747.
    • (2012) Diabetes Technol Ther , vol.14 , pp. 741-747
    • Aronson, R.1
  • 6
    • 0021223411 scopus 로고
    • Insulin therapy in obese, non-insulin-dependent diabetes induces improvements in insulin action and secretion that are maintained for two weeks after insulin withdrawal
    • Andrews WJ, Vasquez B, Nagulesparan M, Klimes I, Foley J, Unger R, Reaven GM: Insulin therapy in obese, noninsulin-dependent diabetes induces improvements in insulin action and secretion that are maintained for two weeks after insulin withdrawal. Diabetes 1984;33:634-642. (Pubitemid 14087554)
    • (1984) Diabetes , vol.33 , Issue.7 , pp. 634-642
    • Andrews, W.J.1    Vasquez, B.2    Nagulesparan, M.3
  • 7
    • 0037232340 scopus 로고    scopus 로고
    • Treatment with intravenous insulin followed by continuous subcutaneous insulin infusion improves glycaemic control in severely resistant Type 2 diabetic patients
    • DOI 10.1046/j.1464-5491.2003.00848.x
    • Pouwels MJ, Tack CJ, Hermus AR, Lutterman JA: Treatment with intravenous insulin followed by continuous subcutaneous insulin infusion improves glycaemic control in severely resistant Type 2 diabetic patients. Diabet Med 2003;20:76-79. (Pubitemid 36098869)
    • (2003) Diabetic Medicine , vol.20 , Issue.1 , pp. 76-79
    • Pouwels, M.-J.J.1    Tack, C.J.2    Hermus, A.R.3    Lutterman, J.A.4
  • 8
    • 0035408217 scopus 로고    scopus 로고
    • The use of continuous insulin delivery systems in severely insulinresistant patients
    • Wainstein J, Metzger M, Wexler ID, Cohen J, Raz I: The use of continuous insulin delivery systems in severely insulinresistant patients. Diabetes Care 2001;24:1299.
    • (2001) Diabetes Care , vol.24 , pp. 1299
    • Wainstein, J.1    Metzger, M.2    Wexler, I.D.3    Cohen, J.4    Raz, I.5
  • 9
    • 77957674316 scopus 로고    scopus 로고
    • Insulin pump therapy in patients with type 2 diabetes safely improved glycemic control using a simple insulin dosing regimen
    • Edelman SV, Bode BW, Bailey TS, Kipnes MS, Brunelle R, Chen X, Frias JP: Insulin pump therapy in patients with type 2 diabetes safely improved glycemic control using a simple insulin dosing regimen. Diabetes Technol Ther 2010;12:627-633.
    • (2010) Diabetes Technol Ther , vol.12 , pp. 627-633
    • Edelman, S.V.1    Bode, B.W.2    Bailey, T.S.3    Kipnes, M.S.4    Brunelle, R.5    Chen, X.6    Frias, J.P.7
  • 10
    • 70349459325 scopus 로고    scopus 로고
    • Reduction of glycosylated hemoglobin following 6 months of continuous subcutaneous insulin infusion in an Indian population with type 2 diabetes
    • Kesavadev J, Balakrishnan S, Ahammed S, Jothydev S: Reduction of glycosylated hemoglobin following 6 months of continuous subcutaneous insulin infusion in an Indian population with type 2 diabetes. Diabetes Technol Ther 2009;11:517-521.
    • (2009) Diabetes Technol Ther , vol.11 , pp. 517-521
    • Kesavadev, J.1    Balakrishnan, S.2    Ahammed, S.3    Jothydev, S.4
  • 11
    • 78650131036 scopus 로고    scopus 로고
    • Efficacy of continuous subcutaneous insulin infusion in type 2 diabetes mellitus: A survey on a cohort of 102 patients with prolonged follow-up
    • Reznik Y, Morera J, Rod A, Coffin C, Rousseau E, Lireux B, Joubert M: Efficacy of continuous subcutaneous insulin infusion in type 2 diabetes mellitus: A survey on a cohort of 102 patients with prolonged follow-up. Diabetes Technol Ther 2010;12:931-936.
    • (2010) Diabetes Technol Ther , vol.12 , pp. 931-936
    • Reznik, Y.1    Morera, J.2    Rod, A.3    Coffin, C.4    Rousseau, E.5    Lireux, B.6    Joubert, M.7
  • 12
    • 84891819100 scopus 로고    scopus 로고
    • Insulin pump for type 2 diabetes: Use and misuse of continuous subcutaneous insulin infusion in type 2 diabetes
    • Reznik Y, Cohen O: Insulin pump for type 2 diabetes: Use and misuse of continuous subcutaneous insulin infusion in type 2 diabetes. Diabetes Care 2013;36(Suppl 2):S219-S225.
    • (2013) Diabetes Care , vol.36 , Issue.SUPPL. 2 , pp. 219-225
    • Reznik, Y.1    Cohen, O.2
  • 14
    • 0042824199 scopus 로고    scopus 로고
    • Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: A randomized, parallel-group, 24-week study
    • DOI 10.2337/diacare.26.9.2598
    • Raskin P, Bode BW, Marks JB, Hirsch IB, Weinstein RL, McGill JB, Peterson GE, Mudaliar SR, Reinhardt RR: Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: A randomized, parallel-group, 24-week study. Diabetes Care 2003;26:2598-2603. (Pubitemid 37052106)
    • (2003) Diabetes Care , vol.26 , Issue.9 , pp. 2598-2603
    • Raskin, P.1    Bode, B.W.2    Marks, J.B.3    Hirsch, I.B.4    Weinstein, R.L.5    McGill, J.B.6    Peterson, G.E.7    Mudaliar, S.R.8    Reinhardt, R.R.9
  • 15
    • 34147219083 scopus 로고    scopus 로고
    • Effectiveness of intensive insulin therapy by multiple daily injections and continuous subcutaneous infusion: A comparison study in type 2 diabetes with conventional insulin regimen failure
    • DOI 10.1055/s-2007-970423
    • Berthe E, Lireux B, Coffin C, Goulet-Salmon B, Houlbert D, Boutreux S, Fradin S, Reznik Y: Effectiveness of intensive insulin therapy by multiple daily injections and continuous subcutaneous infusion: A comparison study in type 2 diabetes with conventional insulin regimen failure. Horm Metab Res 2007;39:224-229. (Pubitemid 46580623)
    • (2007) Hormone and Metabolic Research , vol.39 , Issue.3 , pp. 224-229
    • Berthe, E.1    Lireux, B.2    Coffin, C.3    Goulet-Salmon, B.4    Houlbert, D.5    Boutreux, S.6    Fradin, S.7    Reznik, Y.8
  • 19
    • 1842730273 scopus 로고    scopus 로고
    • Increasing the sample size when the unblinded interim result is promising
    • DOI 10.1002/sim.1688
    • Chen YH, DeMets DL, Lan KK: Increasing the sample size when the unblinded interim result is promising. Stat Med 2004;23:1023-1038. (Pubitemid 38477065)
    • (2004) Statistics in Medicine , vol.23 , Issue.7 , pp. 1023-1038
    • Chen, Y.H.J.1    DeMets, D.L.2    Lan, K.K.G.3
  • 20
    • 84871651612 scopus 로고    scopus 로고
    • Analysis of longitudinal clinical trials with missing data using multiple imputation in conjunction with robust regression
    • Mehrotra DV, Li X, Liu J, Lu K: Analysis of longitudinal clinical trials with missing data using multiple imputation in conjunction with robust regression. Biometrics 2012;68: 1250-1259.
    • (2012) Biometrics , vol.68 , pp. 1250-1259
    • Mehrotra, D.V.1    Li, X.2    Liu, J.3    Lu, K.4
  • 22
    • 0036835927 scopus 로고    scopus 로고
    • Dutch insulin pump study group: A randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycemic control
    • DeVries JH, Snoek FJ, Kostense PJ, Masurel N, Heine RJ; Dutch Insulin Pump Study Group: A randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycemic control. Diabetes Care 2002;25:2074-2080.
    • (2002) Diabetes Care , vol.25 , pp. 2074-2080
    • Devries, J.H.1    Snoek, F.J.2    Kostense, P.J.3    Masurel, N.4    Heine, R.J.5
  • 23
    • 33645051721 scopus 로고    scopus 로고
    • 5-Nations study group: Comparison of the effects of continuous subcutaneous insulin infusion (csii) and nph-based multiple daily insulin injections (mdi) on glycaemic control and quality of life: Results of the 5-Nations Trial
    • Hoogma RP, Hammond PJ, Gomis R, Kerr D, Bruttomesso D, Bouter KP, Wiefels KJ, de la Calle H, Schweitzer DH, Pfohl M, Torlone E, Krinelke LG, Bolli GB; 5-Nations Study Group: Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: Results of the 5-Nations Trial. Diabet Med 2006;23:141-147.
    • (2006) Diabet Med , vol.23 , pp. 141-147
    • Hoogma, R.P.1    Hammond, P.J.2    Gomis, R.3    Kerr, D.4    Bruttomesso, D.5    Bouter, K.P.6    Wiefels, K.J.7    De La Calle, H.8    Schweitzer, D.H.9    Pfohl, M.10    Torlone, E.11    Krinelke, L.G.12    Bolli, G.B.13
  • 24
    • 54949085654 scopus 로고    scopus 로고
    • Action to control cardiovascular risk in diabetes study group: Effects of intensive glucose lowering in type 2 diabetes
    • Action to Control Cardiovascular Risk in Diabetes Study Group: Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;23;358:2545-2559.
    • (2008) N Engl J Med , vol.23 , Issue.358 , pp. 2545-2559


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.